  |
|
 |
 |
About the Summit |
| CTIC Capital is dedicated to creating valuable connections through the annual summit for US companies that are interested in raising capital and developing business relationships in China. |
 |
Get ready to pitch
 We will bring you Chinese investors (150) who are actively searching for investing and business collaborating opportunities in the US. New for 2018, we will select 6-8 companies out of hundreds of applications to present and be evaluated by investors. |
 |
Get ready to be inspired
Impressive line up of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more. |
 |
Get ready to connect
One-on-One partnering system will assist you in submitting inquiries for One-on-One meetings. The system will
open by December 15th, 2017. |
Speakers |
 |
 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Randy W. Schekman (Keynote) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine Professor of Molecular and Cell Biology, University of California, Berkeley |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Agenda |
|
| MORNING SESSION | |||
| 08:00-09:20AM | Registration / Networking / Breakfast | ||
| 09:20-09:25AM | Welcoming Remarks | ||
| Yanhong Lin, Managing Partner, CTIC Capital | |||
| 09:25-10:10AM | Keynote Speech: Prospects for Use of Exosomes in Cancer Diagnosis and Treatment | ||
| Randy W. Schekman, Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine | |||
| 10:10-10:55AM | Panel Discussion I: Chinese Investment & M&A Opportunities – Where Is the Money? | ||
| Alexis Ji, Parnter, Illumina Ventures (Panel Lead) James Huang, Managing Partner, KPCB China Hongbo Lu, Partner, Lilly Asia Ventures Xiaobo Lu, Partner, Sequoia Capital China Jerry Xiao, CEO, Hermed Capital |
|||
| 10:55-11:40AM | Panel Discussion II: Successful Equity Investments and M&A & Why Others Failed | ||
| Karen Wong, Partner, Intellectual Property, WSGR (Panel Lead) Hai Mi, Founding Managing Partner, Panacea Venture Christopher Shen, Managing Partner, Qiming Venture Parners Alvin Syh, CEO, Buchang Asset Management; General Manager, Anrich Capital Asia Grace Xu, SVP for Biomedicine Business, SanPower; Chairwoman, Denderon Corporation |
|||
| 11:40-12:55PM | Lunch / Special Session Hosted by WSGR: Capitalizing On Cross-Border Healthcare Investments, M&A, and Public Offerings | ||
| Michael Chan, SVP, Hong Kong Exchanges and Clearing Ltd.("HKEX") Derek Liu, Partner-Elect, Mergers & Acquisitions, WSGR Khoon Jin Tan, Partner, Corporate, WSGR Barry Taylor, Partner, Corporate, WSGR Karen Wong, Partner, Intellectual Property, WSGR |
|||
| AFTERNOON SESSION | |||
| 12:55-01:55PM | Company Presentations: Epic Sciences, Tessa Therapeutics, Sera Prognostics | ||
| Hongjie Hu, Investment Director, Temasek Yingying Chen, Executive Director, GF Investments (Hong Kong) Company Limited Jiang Zhang, Managing Director, Ping An Venture |
|||
| 01:55-02:40PM | Panel Discussion III: US Healthcare Investment Trend – Where Would the US VCs Invest in Healthcare? | ||
| Doug Fisher, Partner, InterWest Partners (Panel Lead) Ted Driscoll, Managing Director, DigitalDx Ventures Julie Papanek Grant, Partner, Canaan Patrick Heron, Managing General Partner, Frazier Healthcare Partners Amy Schulman, Entrepreneur Partner, Polaris Partners |
|||
| 02:40-02:55PM | Break | ||
| 02:55-03:55PM | Company Presentations: Quantapore, BioClin Therapeutics, Connect Biopharma | ||
| Kevin Chen, Founding Partner, Biotrack Capital Lily Zhang, Partner, CDH Venture David Flores, Co-Founder, President & CEO, BioCentury |
|||
| 03:55-04:40PM | Panel Discussion IV: Cross-Border Business Development, Joint Venture, and Licensing Opportunities | ||
| Samantha Du, Chairman and CEO, Zai Lab Nisa Leung, Managing Partner, Qiming Ventures Partners Frank Zhang, CEO, GenScript; Chairman, Nanjing Legend Richard Zhao, GM Strategy and Investment & SVP, Medical Device, Fosun Pharma |
|||
| 04:40-05:00PM | Closing | ||
| 05:00-07:00PM | Networking | ||
Overview of 2017 CTIC Capital |
